Posts for the 'Headlines' Category
Byetta Pancreatitis Lawsuit Evaluations
The product liability lawyers at Saiontz, Kirk & Miles, P.A. are now reviewing and evaluating potential Byetta lawsuits for individuals diagnosed with pancreatitis after receiving the type 2 diabetes injection to help lower their blood glucose levels. Byetta has been associated with a number of reports of acute pancreatitis, hemorrhagic pancreatitis and necrotizing pancreatitis.
Byetta Pancreatitis Risk Highlighted by FDA
The FDA has issued another warning to doctors about reports of users of Byetta developing pancreatitis. Following an earlier alert issued in October 2007, the FDA indicates that they have received at least six new cases of hemorrhagic pancreatitis or necrotizing pancreatitis associated with Byetta side effects. Two of these cases resulted in death.
>>PRIOR POST (10/17/2007): Byetta Pancreatitis Side Effects
Digoxin Lawsuit Consolidation in West Virginia
Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R. Goodwin.
Generic Fentanyl Pain Patch Recall
For the fourth time this year, a generic fentanyl pain patch recall was issued because some patches have been found to be leaking fentanyl gel, which could cause a fentanyl overdose or death. The latest recall was issued by Watson Pharmaceuticals, Inc. for one lot of their 75 mcg/hr Fentanyl Transdermal System pain patches, which were sold throughout the United States.
>>INFORMATION: Fentanyl Pain Patch Lawsuits
Zimmer Durom Cup Class Action Lawsuit
On July 22, 2008, Zimmer announced that they were suspending sales of their Durom Cup hip implant due to an unusually high number of reported failures and hip revisions. While our product liability lawyers at Saiontz, Kirk & Miles, P.A. are reviewing individual Zimmer lawsuits on behalf of individuals who have suffered injuries, the first Zimmer class action suit was filed in federal court on behalf of shareholders who claim that the company’s failure to disclose the Durom Cup problems caused a sudden drop in the price of their stock.
Baltimore Medicine Shoppe Lawsuits: Expired and Counterfeit Drugs
Late Friday, the FDA posted a warning to Baltimore residents who filled prescriptions at two Medicine Shoppe pharmacies. Expired drugs and potentially counterfeit medications could have been distributed by the Baltimore pharmacy. The lawyers at Saiontz, Kirk & Miles, P.A., who are based in Baltimore, Maryland, are evaluating potential lawsuits on behalf of customers who suffered severe injuries or reactions to the medications.
>>INFORMATION: Pharmacy Mistake Lawsuits
Chantix No Better Than Nicoderm in Long Term Quit Rates
A new study reveals that there is no significant difference between Chantix and NicoDerm in long-term quit rates for smokers. As concerns continue to mount about the safety of Chantix and suicide related side effects, the study raises more questions about whether the risks outweigh the potential benefits of the treatment.
>>INFORMATION: Chantix Lawsuits
Following Digitek recall, Actavis issues recall for 65 other drugs made at same plant
On Monday, Actavis Totowa, LLC, the maker of Digitek, recalled over 65 different generic drugs made at their New Jersey manufacturing plant. Following an FDA inspection earlier this year, a number of violations of good manufacturing practices were identified. In April 2008, Actavis issued a Digitek recall for all lots of their generic digoxin which were made at the same plant, after they discovered that tablets had been commercially sold which were twice as thick as they were supposed to be.
>>PRIOR POST (5/4/2008): Digitek Recall Due to Risk of Digoxin Overdose
Zimmer Durom Cup problems could have been discovered sooner
An article in today’s edition of the New York Times highlights the lack of tracking system in place in the United States, which may have alerted doctors sooner to the Zimmer Durom Cup problems which eventually led the manufacturer to suspend sales last week. The decision to stop selling the product in the U.S. came months after doctors first started complaining that patients were experiencing loosening of their Zimmer Durom Cup artificial hip and required revisions of their hip replacements at an alarming rate.
>>INFORMATION: Zimmer Durom Cup Lawsuits
Zimmer Durom Cup Lawsuits: Hip Replacement Part Sales Suspended
Sales have been suspended in the United States for the Zimmer Durom Cup hip replacement component, since many doctors have reported a substantially higher need for revisions and further hip surgery. The product liability lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Zimmer hip replacement lawsuits for individuals who received the Durom Cup and have experienced problems more than three months after surgery or required additional surgeries or revisions.
